Synopsis
Coordinate safe care for a child with a rare or undiagnosed condition, maintain a shared clinical summary and emergency plan, reduce diagnostic and appointment burden, support family wellbeing and deliver purposeful transition and genomic review.
- Rare disease care is organised around function and risk, not only a diagnostic name; a child without a molecular diagnosis still needs coordinated treatment and support.
- Nominate one lead clinician and one care coordinator who track referrals, results, surveillance, medicines, equipment, school needs and communication across organisational boundaries.
- Maintain a short parent- and professional-held summary containing diagnosis or working formulation, baseline, communication method, emergency risks, current medicines, devices, allergies, specialists and escalation contacts.
- Create an emergency plan that specifies early warning signs, samples before treatment when safe, time-critical therapies, procedures to avoid and who can authorise specialist deviations.
- Cluster appointments and blood tests where possible, reconcile competing specialty advice and distinguish essential surveillance from low-yield repeated investigation.
- Support siblings, parental mental health, sleep, finances, transport, housing, school inclusion, respite and benefits because practical strain directly affects health outcomes.
- Revisit genomic diagnosis when phenotype evolves or analysis improves, but avoid making every appointment another diagnostic search when the family prioritises stability and participation.
- Begin transition early with a named worker, direct young-person involvement, adult-service ownership, equipment and prescription continuity, and at least one tested emergency handover.
Key red flags
Reduced consciousness, persistent vomiting, fasting intolerance, hypoglycaemia, acidosis or hyperammonaemia in a child with a metabolic or undiagnosed disorder requires the emergency metabolic pathway.
Stridor, escalating work of breathing, ineffective cough, new oxygen need or recurrent aspiration can deteriorate rapidly in a child with craniofacial, neuromuscular or complex disability.
Syncope, sustained palpitations, chest pain or family sudden death needs urgent cardiac assessment even when previous symptoms were attributed to the rare condition.
Loss of previously acquired skills, new focal signs, prolonged seizure or a marked change from neurological baseline warrants urgent assessment for treatable complications.
Caregiver exhaustion, missed essential treatment, escalating restraint, unexplained injury or inability to provide safe overnight care requires same-day practical and safeguarding support, not blame.
A new medicine prescribed without review of the child's disease, organ function, route, excipients and interaction plan can cause avoidable harm and should be checked promptly.
Investigation priorities
Reconcile diagnoses, medicines, imaging, genomic reports, surveillance and unresolved actions across teams.
Management branches
Multiple teams manage a rare or unresolved multisystem condition.
- Name a lead clinician and coordinator and map every specialty, surveillance item, medicine and device.
- Reconcile conflicting recommendations and rank actions by safety, benefit and family burden.
- Issue a dated concise summary with owners, deadlines, contacts and pending results.